|

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

RECRUITINGN/ASponsored by Dharmais National Cancer Center Hospital
Actively Recruiting
PhaseN/A
SponsorDharmais National Cancer Center Hospital
Started2024-03-18
Est. completion2027-03-21
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07233863

Summary

This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Breast cancer patients aged ≥ 18 years with an ECOG score \> 1
* Breast cancer patients with post-axillary lymph node dissection diagnosed with stage 0 and I lymphedema.
* Those who have never undergone lymphedema physiotherapy.

Exclusion Criteria:

* Patients with dermal backflow before axillary lymph node dissection (ALND).
* Patients with breast cancer lymphedema who are unable to undergo a 24-month follow-up at Dharmais Cancer Hospital.
* Patients with iodine allergy, severe asthma, decreased kidney function, pregnancy, or breastfeeding.

Conditions3

Breast CancerCancerLymphedema Arm

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.